237 related articles for article (PubMed ID: 24457397)
1. Subclinical hypothyroidism and vascular risk: an update.
Lioudaki E; Mavroeidi NG; Mikhailidis DP; Ganotakis ES
Hormones (Athens); 2013; 12(4):495-506. PubMed ID: 24457397
[TBL] [Abstract][Full Text] [Related]
2. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial.
Razvi S; Ingoe L; Keeka G; Oates C; McMillan C; Weaver JU
J Clin Endocrinol Metab; 2007 May; 92(5):1715-23. PubMed ID: 17299073
[TBL] [Abstract][Full Text] [Related]
3. Impact of Thyroid Hormone Therapy on Atherosclerosis in the Elderly With Subclinical Hypothyroidism: A Randomized Trial.
Blum MR; Gencer B; Adam L; Feller M; Collet TH; da Costa BR; Moutzouri E; Dopheide J; Depairon M; Sykiotis GP; Kearney P; Gussekloo J; Westendorp R; Stott DJ; Bauer DC; Rodondi N
J Clin Endocrinol Metab; 2018 Aug; 103(8):2988-2997. PubMed ID: 29846630
[TBL] [Abstract][Full Text] [Related]
4. Evaluation response and effectiveness of thyroid hormone replacement treatment on lipid profile and function in elderly patients with subclinical hypothyroidism.
Arinzon Z; Zuta A; Peisakh A; Feldman J; Berner Y
Arch Gerontol Geriatr; 2007; 44(1):13-9. PubMed ID: 16621071
[TBL] [Abstract][Full Text] [Related]
5. Effect of Thyroxin Treatment on Carotid Intima-Media Thickness (CIMT) Reduction in Patients with Subclinical Hypothyroidism (SCH): a Meta-Analysis of Clinical Trials.
Aziz M; Kandimalla Y; Machavarapu A; Saxena A; Das S; Younus A; Nguyen M; Malik R; Anugula D; Latif MA; Humayun C; Khan IM; Adus A; Rasool A; Veledar E; Nasir K
J Atheroscler Thromb; 2017 Jul; 24(7):643-659. PubMed ID: 28566564
[TBL] [Abstract][Full Text] [Related]
6. Association of Subclinical Hypothyroidism with Dyslipidemia and Increased Carotid Intima-Media Thickness in Children.
Unal E; Akın A; Yıldırım R; Demir V; Yildiz İ; Haspolat YK
J Clin Res Pediatr Endocrinol; 2017 Jun; 9(2):144-149. PubMed ID: 28008862
[TBL] [Abstract][Full Text] [Related]
7. The effect of L-thyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism.
Serter R; Demirbas B; Korukluoglu B; Culha C; Cakal E; Aral Y
J Endocrinol Invest; 2004 Nov; 27(10):897-903. PubMed ID: 15762035
[TBL] [Abstract][Full Text] [Related]
8. Effects of 18 months of L-T4 replacement in women with subclinical hypothyroidism.
Adrees M; Gibney J; El-Saeity N; Boran G
Clin Endocrinol (Oxf); 2009 Aug; 71(2):298-303. PubMed ID: 19094068
[TBL] [Abstract][Full Text] [Related]
9. How selective are the new guidelines for treatment of subclinical hypothyroidism for patients with thyrotropin levels at or below 10 mIU/L?
Rosario PW; Calsolari MR
Thyroid; 2013 May; 23(5):562-5. PubMed ID: 23627903
[TBL] [Abstract][Full Text] [Related]
10. Subclinical hypothyroidism, lipid metabolism and cardiovascular disease.
Delitala AP; Fanciulli G; Maioli M; Delitala G
Eur J Intern Med; 2017 Mar; 38():17-24. PubMed ID: 28040402
[TBL] [Abstract][Full Text] [Related]
11. Studies of cardiovascular risk factors in polycystic ovary syndrome patients combined with subclinical hypothyroidism.
Pei YJ; Wang AM; Zhao Y; Yan L; Li M; White RE; Han GC
Gynecol Endocrinol; 2014 Aug; 30(8):553-6. PubMed ID: 24884959
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence?
Duntas LH; Wartofsky L
Thyroid; 2007 Nov; 17(11):1075-84. PubMed ID: 17900236
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Selected Atherosclerosis Risk Factors in Women with Subclinical Hypothyroidism Treated with L-Thyroxine.
Adamarczuk-Janczyszyn M; Zdrojowy-Wełna A; Rogala N; Zatońska K; Bednarek-Tupikowska G
Adv Clin Exp Med; 2016; 25(3):457-63. PubMed ID: 27629733
[TBL] [Abstract][Full Text] [Related]
14. Does treating subclinical hypothyroidism improve markers of cardiovascular risk?
Monzani F; Dardano A; Caraccio N
Treat Endocrinol; 2006; 5(2):65-81. PubMed ID: 16542047
[TBL] [Abstract][Full Text] [Related]
15. Serum irisin and apelin levels and markers of atherosclerosis in patients with subclinical hypothyroidism.
Yasar HY; Demirpence M; Colak A; Yurdakul L; Zeytinli M; Turkon H; Ekinci F; Günaslan A; Yasar E
Arch Endocrinol Metab; 2019 Feb; 63(1):16-21. PubMed ID: 30864627
[TBL] [Abstract][Full Text] [Related]
16. Subclinical hypothyroidism is associated with higher carotid intima-media thickness in cross-sectional analysis of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Peixoto de Miranda ÉJ; Bittencourt MS; Pereira AC; Goulart AC; Santos IS; Lotufo PA; Bensenor IM
Nutr Metab Cardiovasc Dis; 2016 Oct; 26(10):915-21. PubMed ID: 27389191
[TBL] [Abstract][Full Text] [Related]
17. Lipid profile and lipoprotein (a) as a risk factor for cardiovascular disease in women with subclinical hypothyroidism.
Canturk Z; Cetinarslan B; Tarkun I; Canturk NZ; Ozden M
Endocr Res; 2003 Aug; 29(3):307-16. PubMed ID: 14535632
[TBL] [Abstract][Full Text] [Related]
18. Iodine treatment in children with subclinical hypothyroidism due to chronic iodine deficiency decreases thyrotropin and C-peptide concentrations and improves the lipid profile.
Zimmermann MB; Aeberli I; Melse-Boonstra A; Grimci L; Bridson J; Chaouki N; Mbhenyane X; Jooste PL
Thyroid; 2009 Oct; 19(10):1099-104. PubMed ID: 19534625
[TBL] [Abstract][Full Text] [Related]
19. Carotid Intima-Media Thickness in Patients with Subclinical Hypothyroidism: A Prospective Controlled Study.
Soto-García AJ; Elizondo-Riojas G; Rodriguez-Gutiérrez R; Mancillas-Adame LG; González-González JG
Clin Invest Med; 2021 Dec; 44(4):E39-45. PubMed ID: 34978774
[TBL] [Abstract][Full Text] [Related]
20. Subclinical hypothyroidism and cardiovascular risk: a reason to treat?
Palmieri EA; Fazio S; Lombardi G; Biondi B
Treat Endocrinol; 2004; 3(4):233-44. PubMed ID: 16026106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
